Hansa Biopharma AB (publ) announced the current chairman of the board of directors Ulf Wiinberg has chosen to not stand for re-election. Ulf Wiinberg has been chair of the Board of Directors since 2016 and the Nomination Committee would like to thank Ulf for his great contributions and strong engagement during his extensive tenure as board member and chair of the Board of Directors. His role in the development of the company over the past years cannot be overstated.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.3 SEK | +0.83% | -3.62% | +11.83% |
Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.83% | 146M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- HNSA Stock
- News Hansa Biopharma AB
- Hansa Biopharma AB Announces Not Stand for Re-Election of Ulf Wiinberg as Chairman of the Board of Directors